Search
for
Sort by
Research 241–270 of 1000+
- Cetuximab-Associated Elongation of the Eyelashes
- Matriptase: Potent Proteolysis on the Cell Surface
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Prostatakarzinom
- Tamoxifen-Induced Total Alopecia
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Hormone Blocking Anticancer Drugs
- New Drugs for Leukæmia and Tumours
- A matter of excessive hair growth
- Highway Deconstruction
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Two Opposing Faces of Retinoic Acid: Induction of Stemness or Induction of Differentiation Depending on Cell-Type
- Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways
- INTERSTITIAL CELL TUMOR IN A BLACK-AND-WHITE RUFFED LEMUR (VARECIA VARIEGATUS VARIEGATUS)
- ApoBDs: a paradigm shift from cellular debris to therapeutic vehicles
- Four Closure
- Finding Parallels
- Scalp cooling to prevent chemotherapy-induced alopecia
- Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors
- 5α‐Reductase Inhibitors
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
- The Chinese State Food and Drug Administration has issued Sinovac Biotech a New Drug Certificate approving its split influenza vaccine
- Therapeutic Strategies to Target the Androgen Receptor
- Cytokeratin 7 and 20
- LOP14
- LOP14
- Basal cell carcinoma — molecular biology and potential new therapies
- Hand-Foot and Stump Syndrome to Sorafenib